Healthcare | September 06, 2021
Brinton launches Hohner Health in India
The focus is on wellness and personal care products
The focus is on wellness and personal care products
The investment will establish drug product manufacturing capacity for clinical trial and commercial supply in China and offer customers combined drug substance and drug product manufacturing services
It strengthens its presence to over 250 stores
Ayush Ministry will conduct the study along with the UK’s London School of Hygiene and Tropical Medicine
The company posted net profit of Rs.594.6 crores for the period ended June 30, 2020.
The company has now received the renewed GMP (Good Manufacturing Practices) certificate thereby confirming the successful closure of the inspection
The deal is to sell one of the two business undertakings of ZAHL for a lump sum consideration of Rs. 2921 crores on a cash free and debt free basis,
The rating withdrawal is based on the company’s request and in line with CRISIL Rating’s policy on withdrawal of ratings.
In animal health, the products will be mainly targeting mastitis and production disorders, gastrointestinal tract diseases, reproductive disorders, ectoparasites, and skin injuries
Subscribe To Our Newsletter & Stay Updated
